Dr. Mårten Svensson is currently holding a position as CEO at Emmace Consulting which he founded in 2011. Prior to this position, he worked at AstraZeneca for thirteen years as Associate Principal Scientist within Inhalation Technology and has during this time worked with particle sizing using different approaches such as lung dose prediction models, impaction methodology, fast screening methods, various automation projects and device development of dry powder inhalers. For several years, he has been a member in industry-wide organizations such as the EPAG as well as the Cascade Impactor Working Group of IPAC-RS.

Mårten has a PhD in surface and colloid science and has published several articles, posters, and book chapters in the inhalation field.